Technical Analysis for CSBR - Champions Oncology, Inc.

Grade Last Price % Change Price Change
grade D 9.99 4.28% 0.41
CSBR closed up 4.28 percent on Friday, January 18, 2019, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical CSBR trend table...

Date Alert Name Type % Chg
Jan 18 MACD Bullish Centerline Cross Bullish 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Multiple of Ten Bearish Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion 4.28%
Jan 16 Multiple of Ten Bearish Other 5.60%
Jan 16 Outside Day Range Expansion 5.60%
Jan 16 Wide Bands Range Expansion 5.60%
Jan 15 Wide Bands Range Expansion 1.94%
Jan 15 Overbought Stochastic Strength 1.94%

Older signals for CSBR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.
Is CSBR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.9
52 Week Low 3.045
Average Volume 95,543
200-Day Moving Average 8.5048
50-Day Moving Average 10.254
20-Day Moving Average 8.7025
10-Day Moving Average 9.61
Average True Range 0.7937
ADX 17.58
+DI 22.1216
-DI 17.5898
Chandelier Exit (Long, 3 ATRs ) 7.9689
Chandelier Exit (Short, 3 ATRs ) 9.2411
Upper Bollinger Band 10.6382
Lower Bollinger Band 6.7668
Percent B (%b) 0.83
BandWidth 44.486067
MACD Line 0.0053
MACD Signal Line -0.2433
MACD Histogram 0.2486
Fundamentals Value
Market Cap 109.73 Million
Num Shares 11 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -21.72
Price-to-Sales 2.13
Price-to-Book 125.38
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.69
Resistance 3 (R3) 10.63 10.34 10.57
Resistance 2 (R2) 10.34 10.16 10.37 10.53
Resistance 1 (R1) 10.17 10.05 10.25 10.22 10.49
Pivot Point 9.88 9.88 9.92 9.90 9.88
Support 1 (S1) 9.70 9.70 9.79 9.76 9.49
Support 2 (S2) 9.41 9.59 9.44 9.45
Support 3 (S3) 9.24 9.41 9.41
Support 4 (S4) 9.29